Regulation A · Tier 2
Shackelford Pharma Inc.
Shackelford Pharma Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on May 4, 2020 for up to $10M at $1.00 per security. The SEC qualified the offering on Aug 20, 2020.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $10M
- Offer price
- $1.00
- Security type
- Equity (common or preferred stock)
- Filed
- May 4, 2020
- Qualified
- Aug 20, 2020
- Industry
- Pharmaceutical Preparations
- State
- British Columbia, Canada
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) May 4, 2020
- Final offering circular (253G2)
- All filings on EDGAR CIK 1811112
Other qualified Biotech & pharma Reg A offerings
- Torque Lifestyle Brands, Inc.Dec 29, 2020 · $8M
- Bioquest CorpNov 25, 2020 · $5.1M
- Scopus BioPharma Inc.Sep 23, 2020 · $5.5M
- Cytonics CorpJul 6, 2020 · $19M
- Bioquest CorpMay 22, 2020 · $1M
- Verax Research Services, Inc.May 4, 2020 · $50M